Free Trial

Invivyd (IVVD) Insider Trading & Ownership

Invivyd logo
$0.77 0.00 (0.00%)
(As of 11/20/2024 ET)

Invivyd (NASDAQ:IVVD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$19.94 M
Get IVVD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Invivyd stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IVVD Insider Buying and Selling by Quarter

Invivyd Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/29/2024Terrance McguireDirectorSell112,381$1.66$186,552.46  
1/19/2024Adimab, LlcMajor ShareholderSell5,000,000$3.95$19,750,000.00  
(Data available from 1/1/2013 forward)

IVVD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Invivyd includes Adimab, Llc, and Terrance Mcguire. Learn more on insiders at IVVD.

17.90% of Invivyd stock is owned by insiders. Learn more on IVVD's insider holdings.

The following insiders have sold IVVD shares in the last 24 months: Adimab, Llc ($19,750,000.00), and Terrance Mcguire ($186,552.46).

Insiders have sold a total of 5,112,381 Invivyd shares in the last 24 months for a total of $19,936,552.46 sold.

Invivyd Key Executives

  • Dr. Robert D. Allen Ph.D. (Age 55)
    Chief Scientific Officer
    Compensation: $828.18k
  • Ms. Jill Andersen J.D. (Age 51)
    Chief Legal Officer & Corporate Secretary
    Compensation: $931.68k
  • Mr. Jeremy Gowler (Age 47)
    Interim CEO, COO & Chief Commercial Officer
  • Mr. William E. Duke Jr. (Age 52)
    M.B.A., Chief Financial Officer
  • Ms. Stacy Price M.S. (Age 55)
    Chief Technology & Manufacturing Officer
  • Scott Young
    Senior Vice President of Investor Relations & Corporate Communications
  • Ms. Julie Green M.B.A. (Age 49)
    Chief Human Resources Officer
  • Ms. Heidi Spurling M.S.
    VP of Strategy & Operations and Chief of Staff to the CEO
  • Dr. Mark A. Wingertzahn Ph.D. (Age 53)
    Senior Vice President of Clinical Development & Medical Affairs


This page (NASDAQ:IVVD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners